Categories AlphaGraphs, Earnings, Finance

Nasdaq (NDAQ) reports in line earnings for Q4

Nasdaq’s (NDAQ) Q4 EPS of $1.26 met analysts’ expectations, while revenue of $645 million exceeded the analysts’ views. Street had expected the exchange operator to post earnings of $1.26 per share on revenue of $640 million. Nasdaq stock was trading flat during the first hour of Wednesday’s trading session.

Nasdaq (NDAQ) Q4 2018 earnings infograph

The year-over-year revenue growth of 12% was primarily driven by organic growth of 11% and the acquisition of eVestment. On a GAAP basis, Nasdaq reported a loss of 27 cents per share compared to a profit of $1.45 per share in the year-ago quarter.

“As we begin 2019, we are continuing to execute on our strategy, first with the pivot to maximize opportunities as a technology and analytics provider through our acquisitions of Cinnober and Quandl and second by enhancing our marketplace core through our offer to combine Oslo Bors VPS’ leading Norwegian exchange and depository capabilities with our leading Nordic marketplace complex,” said CEO Adena Friedman.

Nasdaq initiated non-GAAP operating expense guidance for 2019, which is expected to be in the range of $1,325 billion to $1,375 million.

Nasdaq Q3 profit falls 4% but beats estimates

Earlier today, Nasdaq AB, a subsidiary of Nasdaq said that it will make a public offer to acquire shares of Oslo Bors VPS Holding ASA, a Norway=based financial trading company, at NOK 152 per share.

Shares of Nasdaq had gained 4% in both year-to-date and past 12-month periods.

 

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top